Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota

Abstract

Naringenin suppresses epithelial ovarian cancer by inhibiting PI3K pathway expression and ameliorating the gut microbiota, and the oral route is more effective than parenteral administration.